aluates Reports

$ 0.0

Automative

Global Colon Cancer Molecular Diagnostics Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-11V6010

Global Colon Cancer Molecular Diagnostics Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Colon Cancer Molecular Diagnostics Market Research Report 2024

Code: QYRE-Auto-11V6010

Report

February 2024

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

KingMed

Geneis

Unitedgene

Yin Feng Gene

Inmedi

ApexHealth

Amoydx

Genetronhealth

Berryoncology

Topgen

Roche

Qiagen NV

Colon Cancer Molecular Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Colon Cancer Molecular Diagnostics Market

A molecular approach for diagnosing colon cancer

The global Colon Cancer Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Colon Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colon Cancer Molecular Diagnostics.

Report Scope

The Colon Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colon Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Colon Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Colon Cancer Molecular Diagnostics Market Report

Report Metric	Details
Report Name	Colon Cancer Molecular Diagnostics Market
CAGR	5%
Segment by Type	PCR FISH DNA Sequencing Gene Chip
Segment by Application	Clinical Diagnosis Drug Screening Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Kingmed, Geneis, Unitedgene, Yin Feng Gene, Inmedi, ApexHealth, Amoydx, Genetronhealth, Berryoncology, Topgen, Roche, Qiagen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colon Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Colon Cancer Molecular Diagnostics Market report?

Ans: The main players in the Colon Cancer Molecular Diagnostics Market are Kingmed, Geneis, Unitedgene, Yin Feng Gene, Inmedi, ApexHealth, Amoydx, Genetronhealth, Berryoncology, Topgen, Roche, Qiagen

What are the Application segmentation covered in the Colon Cancer Molecular Diagnostics Market report?

Ans: The Applications covered in the Colon Cancer Molecular Diagnostics Market report are Clinical Diagnosis, Drug Screening, Research

What are the Type segmentation covered in the Colon Cancer Molecular Diagnostics Market report?

Ans: The Types covered in the Colon Cancer Molecular Diagnostics Market report are PCR, FISH, DNA Sequencing, Gene Chip

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Colon Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 PCR

1.2.3 FISH

1.2.4 DNA Sequencing

1.2.5 Gene Chip

1.3 Market by Application

1.3.1 Global Colon Cancer Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Diagnosis

1.3.3 Drug Screening

1.3.4 Research

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Colon Cancer Molecular Diagnostics Market Perspective (2019-2030)

2.2 Colon Cancer Molecular Diagnostics Growth Trends by Region

2.2.1 Global Colon Cancer Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Colon Cancer Molecular Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Colon Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Colon Cancer Molecular Diagnostics Market Dynamics

2.3.1 Colon Cancer Molecular Diagnostics Industry Trends

2.3.2 Colon Cancer Molecular Diagnostics Market Drivers

2.3.3 Colon Cancer Molecular Diagnostics Market Challenges

2.3.4 Colon Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Colon Cancer Molecular Diagnostics Players by Revenue

3.1.1 Global Top Colon Cancer Molecular Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Colon Cancer Molecular Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Colon Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Colon Cancer Molecular Diagnostics Revenue

3.4 Global Colon Cancer Molecular Diagnostics Market Concentration Ratio

3.4.1 Global Colon Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Colon Cancer Molecular Diagnostics Revenue in 2023

3.5 Colon Cancer Molecular Diagnostics Key Players Head office and Area Served

3.6 Key Players Colon Cancer Molecular Diagnostics Product Solution and Service

3.7 Date of Enter into Colon Cancer Molecular Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Colon Cancer Molecular Diagnostics Breakdown Data by Type

4.1 Global Colon Cancer Molecular Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030)

5 Colon Cancer Molecular Diagnostics Breakdown Data by Application

5.1 Global Colon Cancer Molecular Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Colon Cancer Molecular Diagnostics Market Size (2019-2030)

6.2 North America Colon Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Colon Cancer Molecular Diagnostics Market Size by Country (2019-2024)

6.4 North America Colon Cancer Molecular Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Colon Cancer Molecular Diagnostics Market Size (2019-2030)

7.2 Europe Colon Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Colon Cancer Molecular Diagnostics Market Size by Country (2019-2024)

7.4 Europe Colon Cancer Molecular Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Colon Cancer Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Colon Cancer Molecular Diagnostics Market Size (2019-2030)

9.2 Latin America Colon Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Colon Cancer Molecular Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Colon Cancer Molecular Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Colon Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Kingmed

11.1.1 Kingmed Company Detail

11.1.2 Kingmed Business Overview

11.1.3 Kingmed Colon Cancer Molecular Diagnostics Introduction

11.1.4 Kingmed Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.1.5 Kingmed Recent Development

11.2 Geneis

11.2.1 Geneis Company Detail

11.2.2 Geneis Business Overview

11.2.3 Geneis Colon Cancer Molecular Diagnostics Introduction

11.2.4 Geneis Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.2.5 Geneis Recent Development

11.3 Unitedgene

11.3.1 Unitedgene Company Detail

11.3.2 Unitedgene Business Overview

11.3.3 Unitedgene Colon Cancer Molecular Diagnostics Introduction

11.3.4 Unitedgene Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.3.5 Unitedgene Recent Development

11.4 Yin Feng Gene

11.4.1 Yin Feng Gene Company Detail

11.4.2 Yin Feng Gene Business Overview

11.4.3 Yin Feng Gene Colon Cancer Molecular Diagnostics Introduction

11.4.4 Yin Feng Gene Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.4.5 Yin Feng Gene Recent Development

11.5 Inmedi

11.5.1 Inmedi Company Detail

11.5.2 Inmedi Business Overview

11.5.3 Inmedi Colon Cancer Molecular Diagnostics Introduction

11.5.4 Inmedi Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.5.5 Inmedi Recent Development

11.6 ApexHealth

11.6.1 ApexHealth Company Detail

11.6.2 ApexHealth Business Overview

11.6.3 ApexHealth Colon Cancer Molecular Diagnostics Introduction

11.6.4 ApexHealth Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.6.5 ApexHealth Recent Development

11.7 Amoydx

11.7.1 Amoydx Company Detail

11.7.2 Amoydx Business Overview

11.7.3 Amoydx Colon Cancer Molecular Diagnostics Introduction

11.7.4 Amoydx Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.7.5 Amoydx Recent Development

11.8 Genetronhealth

11.8.1 Genetronhealth Company Detail

11.8.2 Genetronhealth Business Overview

11.8.3 Genetronhealth Colon Cancer Molecular Diagnostics Introduction

11.8.4 Genetronhealth Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.8.5 Genetronhealth Recent Development

11.9 Berryoncology

11.9.1 Berryoncology Company Detail

11.9.2 Berryoncology Business Overview

11.9.3 Berryoncology Colon Cancer Molecular Diagnostics Introduction

11.9.4 Berryoncology Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.9.5 Berryoncology Recent Development

11.10 Topgen

11.10.1 Topgen Company Detail

11.10.2 Topgen Business Overview

11.10.3 Topgen Colon Cancer Molecular Diagnostics Introduction

11.10.4 Topgen Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.10.5 Topgen Recent Development

11.11 Roche

11.11.1 Roche Company Detail

11.11.2 Roche Business Overview

11.11.3 Roche Colon Cancer Molecular Diagnostics Introduction

11.11.4 Roche Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.11.5 Roche Recent Development

11.12 Qiagen

11.12.1 Qiagen Company Detail

11.12.2 Qiagen Business Overview

11.12.3 Qiagen Colon Cancer Molecular Diagnostics Introduction

11.12.4 Qiagen Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024)

11.12.5 Qiagen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

KingMed

Geneis

Unitedgene

Yin Feng Gene

Inmedi

ApexHealth

Amoydx

Genetronhealth

Berryoncology

Topgen

Roche

Qiagen NV

List of Tables

Table 1. Global Colon Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of PCR

Table 3. Key Players of FISH

Table 4. Key Players of DNA Sequencing

Table 5. Key Players of Gene Chip

Table 6. Global Colon Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Colon Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Colon Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Colon Cancer Molecular Diagnostics Market Share by Region (2019-2024)

Table 10. Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Colon Cancer Molecular Diagnostics Market Share by Region (2025-2030)

Table 12. Colon Cancer Molecular Diagnostics Market Trends

Table 13. Colon Cancer Molecular Diagnostics Market Drivers

Table 14. Colon Cancer Molecular Diagnostics Market Challenges

Table 15. Colon Cancer Molecular Diagnostics Market Restraints

Table 16. Global Colon Cancer Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Colon Cancer Molecular Diagnostics Market Share by Players (2019-2024)

Table 18. Global Top Colon Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colon Cancer Molecular Diagnostics as of 2023)

Table 19. Ranking of Global Top Colon Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Colon Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Colon Cancer Molecular Diagnostics Product Solution and Service

Table 23. Date of Enter into Colon Cancer Molecular Diagnostics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Colon Cancer Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Type (2019-2024)

Table 27. Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Type (2025-2030)

Table 29. Global Colon Cancer Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Application (2019-2024)

Table 31. Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Application (2025-2030)

Table 33. North America Colon Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Colon Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Colon Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Colon Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Colon Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Colon Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Colon Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Colon Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Colon Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Kingmed Company Detail

Table 49. Kingmed Business Overview

Table 50. Kingmed Colon Cancer Molecular Diagnostics Product

Table 51. Kingmed Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 52. Kingmed Recent Development

Table 53. Geneis Company Detail

Table 54. Geneis Business Overview

Table 55. Geneis Colon Cancer Molecular Diagnostics Product

Table 56. Geneis Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 57. Geneis Recent Development

Table 58. Unitedgene Company Detail

Table 59. Unitedgene Business Overview

Table 60. Unitedgene Colon Cancer Molecular Diagnostics Product

Table 61. Unitedgene Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 62. Unitedgene Recent Development

Table 63. Yin Feng Gene Company Detail

Table 64. Yin Feng Gene Business Overview

Table 65. Yin Feng Gene Colon Cancer Molecular Diagnostics Product

Table 66. Yin Feng Gene Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 67. Yin Feng Gene Recent Development

Table 68. Inmedi Company Detail

Table 69. Inmedi Business Overview

Table 70. Inmedi Colon Cancer Molecular Diagnostics Product

Table 71. Inmedi Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 72. Inmedi Recent Development

Table 73. ApexHealth Company Detail

Table 74. ApexHealth Business Overview

Table 75. ApexHealth Colon Cancer Molecular Diagnostics Product

Table 76. ApexHealth Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 77. ApexHealth Recent Development

Table 78. Amoydx Company Detail

Table 79. Amoydx Business Overview

Table 80. Amoydx Colon Cancer Molecular Diagnostics Product

Table 81. Amoydx Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 82. Amoydx Recent Development

Table 83. Genetronhealth Company Detail

Table 84. Genetronhealth Business Overview

Table 85. Genetronhealth Colon Cancer Molecular Diagnostics Product

Table 86. Genetronhealth Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 87. Genetronhealth Recent Development

Table 88. Berryoncology Company Detail

Table 89. Berryoncology Business Overview

Table 90. Berryoncology Colon Cancer Molecular Diagnostics Product

Table 91. Berryoncology Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 92. Berryoncology Recent Development

Table 93. Topgen Company Detail

Table 94. Topgen Business Overview

Table 95. Topgen Colon Cancer Molecular Diagnostics Product

Table 96. Topgen Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 97. Topgen Recent Development

Table 98. Roche Company Detail

Table 99. Roche Business Overview

Table 100. Roche Colon Cancer Molecular Diagnostics Product

Table 101. Roche Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 102. Roche Recent Development

Table 103. Qiagen Company Detail

Table 104. Qiagen Business Overview

Table 105. Qiagen Colon Cancer Molecular Diagnostics Product

Table 106. Qiagen Revenue in Colon Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 107. Qiagen Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Colon Cancer Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Colon Cancer Molecular Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. PCR Features

Figure 4. FISH Features

Figure 5. DNA Sequencing Features

Figure 6. Gene Chip Features

Figure 7. Global Colon Cancer Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Colon Cancer Molecular Diagnostics Market Share by Application: 2023 VS 2030

Figure 9. Clinical Diagnosis Case Studies

Figure 10. Drug Screening Case Studies

Figure 11. Research Case Studies

Figure 12. Colon Cancer Molecular Diagnostics Report Years Considered

Figure 13. Global Colon Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Colon Cancer Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Colon Cancer Molecular Diagnostics Market Share by Region: 2023 VS 2030

Figure 16. Global Colon Cancer Molecular Diagnostics Market Share by Players in 2023

Figure 17. Global Top Colon Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colon Cancer Molecular Diagnostics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Colon Cancer Molecular Diagnostics Revenue in 2023

Figure 19. North America Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Colon Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 21. United States Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Colon Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 25. Germany Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Colon Cancer Molecular Diagnostics Market Share by Region (2019-2030)

Figure 33. China Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Colon Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 41. Mexico Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Colon Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 45. Turkey Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Kingmed Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 48. Geneis Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 49. Unitedgene Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 50. Yin Feng Gene Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 51. Inmedi Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 52. ApexHealth Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 53. Amoydx Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 54. Genetronhealth Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 55. Berryoncology Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 56. Topgen Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 57. Roche Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 58. Qiagen Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Global Liver Cancer Molecular Diagnostics Market Research Report 2024

Global Cervical Cancer Molecular Diagnostics Market Research Report 2024

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Research Report 2024

Global Precancer Molecular Diagnostics Market Research Report 2024

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

Global Brain Cancer Molecular Diagnostics Market Research Report 2024

Global Stomach Cancer Molecular Diagnostics Market Research Report 2024

Global Ovarian Cancer Molecular Diagnostics Market Research Report 2024

Global Melanoma Molecular Diagnostics Market Research Report 2024

Global Pancreatic Cancer Molecular Diagnostics Market Research Report 2024

Global Bladder Cancer Molecular Diagnostics Market Research Report 2024

Global Lymphoma Molecular Diagnostics Market Research Report 2024

Global Skin Cancer Molecular Diagnostics Market Research Report 2024

Global Esophageal Cancer Molecular Diagnosis Market Research Report 2024

Global Molecular Diagnosis of Testicular Cancer Market Research Report 2024

Global Laryngeal Cancer Molecular Diagnostics Market Research Report 2024

Global Oral Cancer Molecular Diagnosis Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22N9079

Fri Apr 25 00:00:00 UTC 2025

Add to Cart

Global Pancreatic Cancer Diagnostic Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-6B9475

Fri Apr 25 00:00:00 UTC 2025

Add to Cart

Global Hydroxycarbamide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-39J9030

Thu Apr 24 00:00:00 UTC 2025

Add to Cart

Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-37Y9103

Wed Apr 23 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »

Global Colon Cancer Molecular Diagnostics Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-11V6010

Global Colon Cancer Molecular Diagnostics Market Research Report 2024

FEATURED COMPANIES

Colon Cancer Molecular Diagnostics Market Size

Colon Cancer Molecular Diagnostics Market

Report Scope

Scope of Colon Cancer Molecular Diagnostics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Colon Cancer Molecular Diagnostics Market report?

What are the Application segmentation covered in the Colon Cancer Molecular Diagnostics Market report?

What are the Type segmentation covered in the Colon Cancer Molecular Diagnostics Market report?

FEATURED COMPANIES

RELATED REPORTS